Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut

Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

More In Business

What’s in the latest version of Trump’s big bill?

At some 940-pages, the legislation is a sprawling collection of tax breaks, spending cuts and other Republican priorities, including new money for national defense and deportations.

‘F1’ opens with $55 million, delivering Apple its biggest big-screen hit

Apple has its first box-office hit. According to studio estimates Sunday, “F1 The Movie” debuted with $55.6 million in North American theaters.

WallStreetBets to Wall Street Wisdom: One-on-One with Jaime Rogozinski

Jaime Rogozinski, founder of WallStreetBets and Chief Strategy Officer of Wire Network, breaks down market volatility and options trading.

Big Business This Week: How to ride the ‘roller coaster of oil prices’

Plus: Why Krispy Kreme left McDonald's, Boeing's latest woes, the potential Shell-BP merger, Bumble's stumble, Nvidia's cloud ambitions, and Meta's AI recr

Is the Heat Off? Key Inflation Data May Signal Shift in Price Pressures

Chris Versace, CIO at Tematica Research, joins to discuss earnings season trends, Flash PMI signals, Walmart’s strategy updates, and Nike’s evolving outlook.

WhatsApp Won’t Be Ad-Free for Long: What You Need to Know

Andrew Nusca, Editorial Director at Fortune, dives into WhatsApp’s first-ever ads rollout —and how Meta’s ad push intensifies its showdown with OpenAI.

Load More